Overview

Clopidogrel Proton-Pump Inhibitors Study

Status:
Withdrawn

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

To find out the impact of two different proton-pump inhibitors (PPIs) (Omeprazole and Pantoprazole) on platelet function in patients with stable coronary artery disease (CAD) on clopidogrel therapy.

Phase:

Phase 4

Details

Lead Sponsor:

Sheba Medical Center

Treatments:

Clopidogrel
Omeprazole
Pantoprazole
Proton Pump Inhibitors